These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9140123)

  • 1. Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma.
    Djonov V; Ball RK; Graf S; Mottaz AE; Arnold AM; Flanders K; Studer UE; Merz VW
    Prostate; 1997 May; 31(2):103-9. PubMed ID: 9140123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors.
    Glynne-Jones E; Harper ME; Goddard L; Eaton CL; Matthews PN; Griffiths K
    Prostate; 1994 Oct; 25(4):210-8. PubMed ID: 7521962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
    Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
    Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer.
    Merz VW; Arnold AM; Studer UE
    World J Urol; 1994; 12(2):96-8. PubMed ID: 7522082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
    Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
    Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.
    Gann PH; Klein KG; Chatterton RT; Ellman AE; Grayhack JT; Nadler RB; Lee C
    Prostate; 1999 Sep; 40(4):248-55. PubMed ID: 10420153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues.
    Gerdes MJ; Larsen M; McBride L; Dang TD; Lu B; Rowley DR
    J Histochem Cytochem; 1998 Mar; 46(3):379-88. PubMed ID: 9487120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
    Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
    Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N; Tu H; Jacobs SC
    Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate.
    Perry KT; Anthony CT; Steiner MS
    Prostate; 1997 Oct; 33(2):133-40. PubMed ID: 9316654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 as a biomarker for prostate cancer.
    Thompson TC; Truong LD; Timme TL; Kadmon D; McCune BK; Flanders KC; Scardino PT; Park SH
    J Cell Biochem Suppl; 1992; 16H():54-61. PubMed ID: 1289674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
    Timme TL; Yang G; Truong LD; Kadmon D; Park SH; Thompson TC
    World J Urol; 1995; 13(6):324-8. PubMed ID: 9116750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
    Cohen P; Nunn SE; Peehl DM
    J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions.
    Timme TL; Yang G; Rogers E; Kadmon D; Morganstern JP; Park SH; Thompson TC
    Lab Invest; 1996 Apr; 74(4):747-60. PubMed ID: 8606485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.